KEY PRODUCTS
Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
01 1Centrient Pharmaceuticals
01 1ROSUVASTATIN CALCIUM
01 1Netherlands
01 1Active
01 1Complete
Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
GDUFA
DMF Review : Complete
Rev. Date : 2017-11-17
Pay. Date : 2017-05-23
DMF Number : 31410
Submission : 2017-03-28
Status : Active
Type : II
20
Centrient Pharmaceuticals Netherlands Bv, based in Netherlands, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
One of their notable products is ROSUVASTATIN CALCIUM, with a corresponding US DMF Number 31410.
Remarkably, this DMF maintains an Active status since its submission on March 28, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 17, 2017, and payment made on May 23, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II
